A Phase 2 interventional study of 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice and 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice in Dentinal Hypersensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-26.
Sponsored by GlaxoSmithKline · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.
This will be a single center, eight week, randomized, controlled, examiner blind, four treatment arms, parallel design study in participants with at least two sensitive teeth that meet all the criteria at the Screening and Baseline visit. Participants will be assessed at baseline, four and eight weeks to monitor clinical efficacy and safety.
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Specific Dentition Exclusions for Test teeth
Dentifrice containing 5.0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate
Drug: 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
Dentifrice containing 0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate
Drug: 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
Dentifrice containing 1000 ppmF as sodium monofluorophosphate
Drug: Sodium monofluorophosphate dentifrice
Dentifrice containing 1100 ppmF as sodium fluoride
Drug: Sodium Fluoride dentifrice
Calcium sodium phosphosilicate dentifrice (5% w/w) and 1500 ppm F as sodium monofluorophosphate
No calcium sodium phosphosilicate and 1500 ppm F as sodium monofluorophosphate
Sodium monofluorophospate dentifrice (1000 ppm F)
Dentifrice containing 1100ppm F as sodium fluoride
Mean Change From Baseline in Schiff Sensitivity Score at Week 4
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus.
Time frame: Baseline and 4 weeks post administration of study treatment
Mean Change From Baseline in Schiff Sensitivity Score at Week 8
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus.
Time frame: Baseline and 8 weeks post administration of study treatment
Median Change From Baseline in Tactile Sensitivity at Week 4
Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.
Time frame: Baseline and 4 weeks post administration of study treatment
Median Change From Baseline in Tactile Sensitivity at Week 8
Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.
Time frame: Baseline and 8 weeks post administration of study treatment
Mean Change From Baseline in Visual Rating Scale Score at Week 4
The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes "No Pain" and 10 denotes "Intense Pain".
Time frame: Baseline and 4 weeks post administration of study treatment
Mean Change From Baseline in Visual Rating Scale Score at Week 8
The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes "No Pain" and 10 denotes "Intense Pain".
Time frame: Baseline and 8 weeks post administration of study treatment
Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire Total Score at Week 4
DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life.
Time frame: Baseline and 4 weeks post administration of study treatment
Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire (DHEQ) Total Score at Week 8
DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life.
Time frame: Baseline and 8 weeks post administration of study treatment
Participants were recruited at the clinical site
| Milestone | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Started | 35 | 34 | 35 | 36 |
| Completed | 31 | 34 | 35 | 36 |
| Not completed | 4 | 0 | 0 | 0 |
| Withdrew: Lost to follow-up | 1 | 0 | 0 | 0 |
| Withdrew: Withdrawl of consent | 3 | 0 | 0 | 0 |
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus.
| Score on a scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 2.39 ± 0.396 | 2.41 ± 0.435 | 2.40 ± 0.417 | 2.38 ± 0.403 |
| Week 4 | 1.83 ± 0.779 | 1.94 ± 0.547 | 2.31 ± 0.516 | 2.31 ± 0.401 |
| Mean change from baseline at Week 4 | -0.56 ± 0.759 | -0.47 ± 0.563 | -0.09 ± 0.445 | -0.07 ± 0.341 |
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus.
| Score on a Scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 2.40 ± 0.396 | 2.41 ± 0.435 | 2.40 ± 0.417 | 2.38 ± 0.403 |
| Week 8 | 1.60 ± 0.987 | 1.56 ± 0.894 | 2.41 ± 0.462 | 2.44 ± 0.427 |
| Mean change from baseline at Week 8 | -0.81 ± 0.972 | -0.85 ± 0.901 | 0.01 ± 0.353 | 0.07 ± 0.450 |
Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.
| grams | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 10.00 (10.0 to 10.0) | 10.00 (10.0 to 10.0) | 10.00 (10.0 to 15.0) | 10.00 (10.0 to 15.0) |
| Week 4 | 10.00 (10.0 to 45.0) | 10.00 (10.0 to 50.0) | 10.00 (10.0 to 15.0) | 10.00 (10.0 to 35.0) |
| Median change from baseline at Week 4 | 0.00 (0.0 to 35.0) | 0.00 (0.0 to 40.0) | 0.00 (-5.0 to 5.0) | 0.00 (-5.0 to 20.0) |
Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.
| grams | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 10.00 (10.0 to 10.0) | 10.00 (10.0 to 10.0) | 10.00 (10.0 to 15.0) | 10.00 (10.0 to 15.0) |
| Week 8 | 15.00 (10.0 to 90.0) | 15.00 (10.0 to 75.0) | 10.00 (10.0 to 55.0) | 10.00 (10.0 to 35.0) |
| Median change from baseline at Week 8 | 5.00 (0.0 to 80.0) | 5.00 (0.0 to 65.0) | 0.00 (-5.0 to 45.0) | 0.00 (0.0 to 20.0) |
The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes "No Pain" and 10 denotes "Intense Pain".
| Score on a scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 6.66 ± 1.886 | 6.69 ± 1.723 | 6.41 ± 1.776 | 6.92 ± 1.783 |
| Week 4 | 5.45 ± 2.212 | 5.72 ± 1.776 | 5.39 ± 1.702 | 6.38 ± 1.814 |
| Mean change from baseline at Week 4 | -1.20 ± 1.727 | -0.97 ± 2.371 | -1.03 ± 1.356 | -0.54 ± 1.742 |
The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes "No Pain" and 10 denotes "Intense Pain".
| Score on a scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 6.71 ± 1.892 | 6.69 ± 1.723 | 6.41 ± 1.776 | 6.92 ± 1.783 |
| Week 8 | 4.65 ± 2.550 | 4.46 ± 2.076 | 5.70 ± 1.914 | 6.07 ± 2.046 |
| Mean change from baseline at Week 8 | -2.06 ± 2.205 | -2.24 ± 2.287 | -0.71 ± 1.559 | -0.86 ± 1.673 |
DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life.
| Score on a scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 136.53 ± 34.194 | 132.55 ± 35.646 | 121.09 ± 44.467 | 133.89 ± 33.638 |
| Mean change from baseline at Week 4 | -3.91 ± 21.850 | -4.39 ± 27.155 | -3.80 ± 24.874 | -7.50 ± 28.905 |
DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life.
| Score on a scale | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| Baseline | 134.33 ± 33.778 | 132.55 ± 35.646 | 120.09 ± 44.614 | 133.89 ± 33.638 |
| Change from baseline at Week 8 | -6.43 ± 28.693 | -7.97 ± 31.324 | -3.88 ± 22.222 | -10.86 ± 33.669 |
Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | — | 0/35 (0%) | 5/35 (14.3%) |
| 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | — | 0/34 (0%) | 3/34 (8.8%) |
| Sodium Monofluorophosphate | — | 0/35 (0%) | 2/35 (5.7%) |
| Sodium Fluoride | — | 0/36 (0%) | 2/36 (5.6%) |
| Event | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride |
|---|---|---|---|---|
| HeadacheNervous system disorders | 1/35 | 2/34 | 1/35 | 2/36 |
| NasopharyngitisRespiratory, thoracic and mediastinal disorders | 2/35 | 0/34 | 0/35 | 0/36 |
| SinusitisInfections and infestations | 0/35 | 1/34 | 0/35 | 0/36 |
| ArthralgiaImmune system disorders | 1/35 | 0/34 | 0/35 | 0/36 |
| ConstipationGastrointestinal disorders | 1/35 | 0/34 | 0/35 | 0/36 |
| Oral HerpesInfections and infestations | 1/35 | 0/34 | 0/35 | 0/36 |
| Urinary Tract InfectionsInfections and infestations | 1/35 | 0/34 | 0/35 | 0/36 |
| Bone PainMusculoskeletal and connective tissue disorders | 1/35 | 0/34 | 0/35 | 0/36 |
| Muscle SpasmsMusculoskeletal and connective tissue disorders | 1/35 | 0/34 | 0/35 | 0/36 |
| PainGeneral disorders | 1/35 | 0/34 | 0/35 | 0/36 |
ITT population consisted of all subjects who were randomized, administered at least one study treatment and provided at least one post-baseline assessment of efficacy. The data of 1 subject in 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate group who was lost to follow up was included in the ITT population.
| Age, Continuous(Years) | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride | Total |
|---|---|---|---|---|---|
| Mean | 36.9 ± 10.08 | 39.6 ± 9.72 | 38.3 ± 8.73 | 42.7 ± 9.10 | 39.5 ± 9.55 |
| Sex: Female, Male(Participants) | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate | Sodium Monofluorophosphate | Sodium Fluoride | Total |
|---|---|---|---|---|---|
| Female | 28 | 32 | 28 | 30 | 118 |
| Male | 4 | 2 | 7 | 6 | 19 |
The record gives a start of Jan 2013, a primary completion of May 2013 and a completion of May 2013. It does not say whether these dates are actual or estimated.
Results were first posted in Mar 2015, 1 year 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.